Given that both NAFLD and CCR5 deficiency significantly elevated the g-MDSC population among hepatic CD45+ leukocytes (Figure 2c), it becomes exceedingly interesting to define the effects of NAFLD microenvironment and CCR5 signaling on g-MDSCs. The gene discussed is CCR5; the disease is metabolic dysfunction-associated steatotic liver disease.